Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
MedTech Acquisition Corporation - Class A Common Stock
(NQ:
MTAC
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 10, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
11.80 (2)
Ask (Size)
12.80 (1)
Prev. Close
11.34
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders
August 02, 2023
From
MedTech Acquisition Corporation
Via
Business Wire
TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting
June 12, 2023
From
TriSalus Life Sciences
Via
Business Wire
Performance
More News
Read More
TriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver Metastases
April 20, 2023
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Goes SPAC Way To Fund Pressure-Enabled Drug Delivery Tech Based Cancer Trials
↗
November 16, 2022
Via
Benzinga
TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business
February 21, 2023
From
TriSalus Life Sciences, Inc.
Via
Business Wire
MedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of Stockholders
December 07, 2022
From
MedTech Acquisition Corporation
Via
GlobeNewswire
Merger Arbitrage Mondays - Google (GOOG) Acquires Cybersecurity Firm Mandiant (MNDT)
↗
March 14, 2022
Via
Benzinga
Surgical Robot Maker Memic Terminates SPAC Merger
↗
March 11, 2022
Via
Benzinga
Memic Going Public Via SPAC: What Investors Should Know About This Medical Device Company
↗
August 13, 2021
Via
Benzinga
'SPACs Attack' Recap: Looking Back At 3 SPAC Deals, SPAC Rumors And The Latest SPAC Headlines And Earnings
↗
May 23, 2021
Via
Benzinga
Frequently Asked Questions
Is MedTech Acquisition Corporation - Class A Common Stock publicly traded?
Yes, MedTech Acquisition Corporation - Class A Common Stock is publicly traded.
What exchange does MedTech Acquisition Corporation - Class A Common Stock trade on?
MedTech Acquisition Corporation - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for MedTech Acquisition Corporation - Class A Common Stock?
The ticker symbol for MedTech Acquisition Corporation - Class A Common Stock is MTAC on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today